metronidazole gel
aidarex pharmaceuticals llc - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole vaginal gel is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, - gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis). note: for purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a ph of greater than 4.5, (b) emits a “fishy” amine odor when mixed with a 10% koh solution, and (c) contains clue cells on microscopic examination. gram’s stain results consistent with a diagnosis of bacterial vaginosis include (a) markedly reduced or absent lactobacillus morphology, (b) predominance of gardnerella morphotype, and (c) absent or few white blood cells. other pathogens commonly associated with vulvovaginitis, e.g., trichomonas vaginalis , chlamydia trachomatis , n. gonorrhoeae , candida albicans , and herpes simplex virus should be ruled out. metronidazole vaginal gel is contraindicated in patient
metronidazole topical cream, 0.75% rx only for topical use only (not for ophthalmic use)
owen laboratories - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole topical cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea. metronidazole topical cream is contraindicated in individuals with a history of hypersensitivity to metronidazole, or other ingredients of the formulation.
metronidazole gel
oceanside pharmaceuticals - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole vaginal gel is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis). other pathogens commonly associated with vulvovaginitis, e.g., trichomonas vaginalis, chlamydia trachomatis, n. gonorrhoeae, candida albicans , and herpes simplex virus should be ruled out. metronidazole vaginal gel is contraindicated in patients with a prior history of hypersensitivity to metronidazole, parabens, other ingredients of the formulation, or other nitroimidazole derivatives.
metronidazole cream
cosette pharmaceuticals, inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole topical cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea. metronidazole topical cream is contraindicated in individuals with a history of hypersensitivity to metronidazole, or other ingredients of the formulation.
metronidazole gel
cosette pharmaceuticals, inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole gel usp is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea. metronidazole gel is contraindicated in individuals with a history of hypersensitivity to metronidazole, parabens, or other ingredients of the formulation.
metronidazole gel
fougera pharmaceuticals inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole gel is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea. metronidazole gel is contraindicated in individuals with a history of hypersensitivity to metronidazole, parabens, or other ingredients of the formulation.
metronidazole gel
sandoz inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole vaginal gel usp, 0.75% is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis). - note: for purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a ph of greater than 4.5, (b) emits a “fishy” amine odor when mixed with a 10% koh solution, and (c) contains clue cells on microscopic examination. gram’s stain results consistent with a diagnosis of bacterial vaginosis include (a) markedly reduced or absent lactobacillus morphology, (b) predominance of gardnerella morphotype, and (c) absent or few white blood cells. note: for purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a ph of greater than 4.5, (b) emits a “fishy” amine odor when mixed with
spiramycine/metronidazole biogaran 750 000 ui/125 mg, comprimé pelliculé
biogaran - spiramycine 750 000 u.i.; métronidazole 125 mg - comprimé - 750 000 u.i. - pour un comprimé > spiramycine 750 000 u.i. > métronidazole 125 mg - associations d'antibacteriens spiramycine et metronidazole - classe pharmacothérapeutique : associations d'antibactériens spiramycine et métronidazole - code atc : j01ra04.ce médicament est une association de deux antibiotiques, un appartenant à la famille des macrolides et l’autre à la famille des imidazolés. les principes actifs sont respectivement la spiramycine et le métronidazole.ce médicament est indiqué chez l’adulte et chez l’enfant dans le traitement d’infections buccales et dentaires (tels que certains abcès dentaires).
spiramycine/metronidazole arrow 750.000 ui/125 mg, comprimé pelliculé
arrow generiques - spiramycine 750 000 u.i.; métronidazole 125 mg - comprimé - 750 000 u.i. - pour un comprimé > spiramycine 750 000 u.i. > métronidazole 125 mg - associations d’antibactériens spiramycine et métronidazole - classe pharmacothérapeutique : associations d’antibactériens, spiramycine et métronidazole – code atc : j01ra04.ce médicament est une association de deux antibiotiques, un appartenant à la famille des macrolides et l’autre à la famille des imidazolés. les principes actifs sont respectivement la spiramycine et le métronidazole.ce médicament est indiqué chez l’adulte et chez l’enfant dans le traitement d’infections buccales et dentaires telles que certains abcès dentaires.
spiramycine/metronidazole arrow 1,5 m.u.i./250 mg, comprimé pelliculé
arrow generiques - spiramycine 1; métronidazole 250 mg - comprimé - 1,5 m.u.i. - pour un comprimé > spiramycine 1,5 m.u.i. > métronidazole 250 mg - associations d’antibactériens spiramycine et métronidazole - classe pharmacothérapeutique : associations d’antibactériens, spiramycine et métronidazole – code atc : j01ra04.ce médicament est une association de deux antibiotiques, un appartenant à la famille des macrolides et l’autre à la famille des imidazolés. les principes actifs sont respectivement la spiramycine et le métronidazole.ce médicament est indiqué chez l’adulte et chez l’enfant dans le traitement d’infections buccales et dentaires telles que certains abcès dentaires.